Human Pharmaceutical and Medicinal Product Manufacturing
ANZSIC class 1841 · 18 mergers
Total reviews
18
Phase 2 reviews
0
Waivers
7
Under assessment
1
Mergers in this industry
- Merck KGaA / Bio-TechneUnder assessment
- Eli Lilly – Merida BiosciencesApproved
- Kirin – Jamieson WellnessNot approved
- Eli Lilly - AtaiBeckley Inc.Approved
- Movac – Advanced NavigationApproved
- AbbVie - ApogeeApproved
- Vertex – CrineticsApproved
- Apollo - Bayer Asset ManagementApproved
- Apollo Capital – CuriaApproved
- CVC Capital Partners and Groupe Bruxelles Lambert – RecordatiApproved
- Eli Lilly - Kelonia TherapeuticsApproved
- Gilead - OuroApproved
- Eli Lilly – acquisition of licence from CSL BehringApproved
- Francisco Partners - Blackline SafetyApproved
- Eli Lilly - Orna TherapeuticsApproved
- CVC Capital Partners – Marathon Asset ManagementApproved
- Gilead - ArcellxApproved
- Eli Lilly – Orna TherapeuticsNot approved